Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « term »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
teriflunomide < term < termed  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000014 (2020) Puja Mehta ; Jessica J. MansonWhat Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000139 (2020) Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000168 (2020) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon]Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000201 (2020) Naomi Serling-Boyd [États-Unis] ; John H. StoneRecent advances in the diagnosis and management of giant cell arteritis.
000289 (2020) Ibrahim Yakoub-Agha [France] ; Christian Chabannon [France] ; Peter Bader [Allemagne] ; Grzegorz W. Basak [Pologne] ; Halvard Bonig [Allemagne] ; Fabio Ciceri [Italie] ; Selim Corbacioglu [Allemagne] ; Rafael F. Duarte [Espagne] ; Hermann Einsele [Allemagne] ; Michael Hudecek [Allemagne] ; Marie José Kersten [Pays-Bas] ; Ulrike Köhl [Allemagne] ; Jürgen Kuball [Pays-Bas] ; Stephan Mielke [Suède] ; Mohamad Mohty [France] ; John Murray [Royaume-Uni] ; Arnon Nagler [Israël] ; Stephen Robinson [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Fermin Sanchez-Guijo [Espagne] ; John A. Snowden [Royaume-Uni] ; Micha Srour [France] ; Jan Styczynski [Pologne] ; Alvaro Urbano-Ispizua [Espagne] ; Patrick J. Hayden [Irlande (pays)] ; Nicolaus Kröger [Allemagne]Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
000297 (2020) Jie Xiao [République populaire de Chine] ; Tian Wang [République populaire de Chine] ; Yi Xu [République populaire de Chine] ; Xiaozhen Gu [République populaire de Chine] ; Danyang Li [République populaire de Chine] ; Kang Niu [République populaire de Chine] ; Tiandong Wang [République populaire de Chine] ; Jing Zhao [République populaire de Chine] ; Ruiqing Zhou [République populaire de Chine] ; Hui-Li Wang [République populaire de Chine]Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats
000298 (2020) Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000387 (2020) Jeffrey P. Jacobs [États-Unis] ; Alfred H. Stammers [États-Unis] ; James St Louis [États-Unis] ; J W Awori Hayanga [États-Unis] ; Michael S. Firstenberg [États-Unis] ; Linda B. Mongero [États-Unis] ; Eric A. Tesdahl [États-Unis] ; Keshava Rajagopal [États-Unis] ; Faisal H. Cheema [États-Unis] ; Tom Coley [États-Unis] ; Vinay Badhwar [États-Unis] ; Anthony K. Sestokas [États-Unis] ; Marvin J. Slepian [États-Unis]Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients.
000403 (2020) Hiroki Hoshino [Japon] ; Yoko Shirai [Japon] ; Hiroe Konishi [Japon] ; Takashi Yamamura [Japon] ; Norikazu Shimizu [Japon]Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy.
000414 (2020) Guiomar Pinheiro [Portugal] ; Ana Rita Costa [Portugal] ; Ana Campar [Portugal] ; Teresa Mendonça [Portugal]Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports
000473 (2020) Konstantinos Thomas [Grèce] ; Emilia Hadziyannis [Grèce] ; Chrisoula Hatzara [Grèce] ; Anastasia Makris [Grèce] ; Christina Tsalapaki [Grèce] ; Argyro Lazarini [Grèce] ; Kalliopi Klavdianou [Grèce] ; Katerina Antonatou [Grèce] ; Christos Koutsianas [Grèce] ; Dimitrios Vassilopoulos [Grèce]Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
000526 (2020) Elena Carboni [Italie] ; Anna Rosa Carta [Italie] ; Ezio Carboni [Italie]Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?
000538 (2020) Debasish Banerjee [Royaume-Uni] ; Joyce Popoola [Royaume-Uni] ; Sapna Shah [Royaume-Uni] ; Irina Chis Ster [Royaume-Uni] ; Virginia Quan [Royaume-Uni] ; Mysore Phanish [Royaume-Uni]COVID-19 infection in kidney transplant recipients
000560 (2020) Ranjit Nair [États-Unis] ; Jason Westin [États-Unis]CAR T-Cells.
000570 (2020) Gisela A. Kristono [Nouvelle-Zélande] ; Ana S. Holley [Nouvelle-Zélande] ; Prashant Lakshman [Nouvelle-Zélande] ; Morgane M. Brunton-O'Sullivan [Nouvelle-Zélande] ; Scott A. Harding [Nouvelle-Zélande] ; Peter D. Larsen [Nouvelle-Zélande]Association between inflammatory cytokines and long-term adverse outcomes in acute coronary syndromes: A systematic review
000572 (2020) Takahiko Sugihara [Japon] ; Hitoshi Hasegawa ; Haruhito A. Uchida [Japon] ; Hajime Yoshifuji [Japon] ; Yoshiko Watanabe [Japon] ; Eisuke Amiya [Japon] ; Yasuhiro Maejima [Japon] ; Masanori Konishi [Japon] ; Yohko Murakawa [Japon] ; Noriyoshi Ogawa [Japon] ; Shunsuke Furuta [Japon] ; Yasuhiro Katsumata [Japon] ; Yoshinori Komagata [Japon] ; Taio Naniwa [Japon] ; Takahiro Okazaki [Japon] ; Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshikazu Nakaoka [Japon] ; Yoshihiro Arimura [Japon] ; Masayoshi Harigai [Japon] ; Mitsuaki Isobe [Japon]Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions
000584 (2020) Itay Lotan [États-Unis] ; Richard Mcgowan [États-Unis] ; Michael Levy [États-Unis]Anti- IL-6 therapies for neuromyelitis optica spectrum disorders: A systematic review of safety and efficacy.
000588 (2020) Gerd R. Burmester [Allemagne] ; Jeffrey R. Curtis [États-Unis] ; Huifeng Yun [États-Unis] ; Oliver Fitzgerald [Irlande (pays)] ; Kevin L. Winthrop [États-Unis] ; Valderilio F. Azevedo ; William F. C. Rigby [États-Unis] ; Keith S. Kanik [États-Unis] ; Cunshan Wang [États-Unis] ; Pinaki Biswas [États-Unis] ; Thomas Jones [États-Unis] ; Niki Palmetto [États-Unis] ; Thijs Hendrikx [États-Unis] ; Sujatha Menon [États-Unis] ; Ricardo Rojo [États-Unis]An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data
000592 (2020) Jinxin Qi [République populaire de Chine, Canada] ; Chengchao Ding [République populaire de Chine] ; Xian Jiang [République populaire de Chine] ; Yong Gao [Canada, République populaire de Chine]Advances in Developing CAR T-Cell Therapy for HIV Cure

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "term" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "term" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    term
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021